UICC TNM 8 th Edition Errata

Similar documents
UICC TNM 8 th Edition Errata

UICC 8 th Edition Errata 25 th of May 2018

UICC 8th Edition Errata 28 th of January 2019

Prognostic factors of genitourinary tumors: Do we have to care?

The pathology of bladder cancer

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

GUIDELINES ON RENAL CELL CANCER

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

TNM Classification of Malignant Tumours 8 th edition

Carcinoma of the Urinary Bladder Histopathology

The 8th Edition Lung Cancer Stage Classification

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES

Staging and Treatment Update for Gynecologic Malignancies

Gastric Cancer Histopathology Reporting Proforma

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

TOPICS FOR DISCUSSION

A215- Urinary bladder cancer tissues

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

Carcinoma of the Renal Pelvis and Ureter Histopathology

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

Urinary Bladder, Ureter, and Renal Pelvis

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

GUIDELINES ON RENAL CELL CARCINOMA

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

AJCC 7th Edition Handbook Errata as of 9/21/10

Testicular Malignancies /8/15

SEER Summary Stage Still Here!

H&E, IHC anti- Cytokeratin

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Guidelines on Renal Cell

Renal Parenchymal Neoplasms

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

GUIDELINES ON PENILE CANCER

Definition of Synoptic Reporting

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

8th Edition of the TNM Classification for Lung Cancer. Proposed by the IASLC

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

EAU GUIDELINES ON PENILE CANCER

Major Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Interactive Staging Bee

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

Oral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi

A916: rectum: adenocarcinoma

The functional anatomy of the urinary system. Human Anatomy Department Dr. Anastasia Bendelic

6 th Reprint Manual Pages AJCC 7 th Edition

STAGE CATEGORY DEFINITIONS

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

EAU GUIDELINES ON PENILE CANCER

The new TNM staging for renal cell carcinoma: what and why the urologists want to know.

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

47. Melanoma of the Skin

LYMPHATIC DRAINAGE IN THE HEAD & NECK

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

GUIDELINES ON PROSTATE CANCER

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

ACCME/Disclosures. 52 year old man who consulted for a long-standing mass on the distal penis 4/13/2016

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

North of Scotland Cancer Network Clinical Management Guideline for Mesothelioma

Cancer: recent advances and implications for underwriting

NAACCR Webinar Series 1

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Summary Stage 2018 (SS2018)

Comprehensive Cancer Cover

GUIDELINES ON PENILE CANCER

Comprehensive cancer cover

AJCC Cancer Staging Form Supplement

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

6 th Reprint Handbook Pages AJCC 7 th Edition

Comparative Analysis of Stage and Other Prognostic Factors Among Urethral, Ureteral, and Renal Pelvis Malignant Tumors

Penile cancer teams in UK. Common variants. Penile cancer teams. Basaloid squamous carcinoma. The Pathology of Penile Tumours

Comprehensive cancer cover

Urinary Bladder, Ureter, and Renal Pelvis

VULVAR CARCINOMA. Page 1 of 5

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

URINARY SYSTEM ANATOMY PART

2018 Implementation: SEER Summary Stage 2018

Transcription:

UICC TNM 8 th Edition Errata ions are in italics Page 28 Oropharynx p16 positive Pathological Stage II,T2 N2 M0 T3 N0,N1 M0 Stage II,T2 N2 M0 T3,T4 N0,N1 M0 Page 61 Oesophagus Adenocarcinoma Pathological Prognostic Group T N M Grade Group IB a N0 M0 2, b N0 M0 1, 2 Group IIIA N2 M0 Any T2 N1 M0 Any T3, N0 M0 Any Group IB a N0 M0 2 b N0 M0 1, 2, X Group IIIA N2 M0 Any T2 N1 M0 Any T3 N0 M0 Any Delete 1

Page 72 Stage IVA Stage IVA Appendix Any T Any N0 M1a Any T Any N M1a Any T Any N M1b G1 Page 92 Ampulla of Vater N Regional Lymph Nodes NX N0 N1 N2 Regional lymph nodes cannot be assessed No regional lymph node metastasis Metastasis in 1 or 2 regional lymph nodes Metastasis in 3 or more regional lymph nodes N Regional Lymph Nodes NX N0 N1 N2 Regional lymph nodes cannot be assessed No regional lymph node metastasis Metastasis in 1 to 3 regional lymph nodes Metastasis in 4 or more regional lymph nodes Page 94 Pancreas Tumour 2 cm or less in greatest dimension a Tumour 0.5 cm or less in greatest dimension b Tumour greater than 0.5 cm and less than 1 cm in greatest dimension c Tumor greater than 1 cm but no more than 2 cm in greatest dimension Tumour 2 cm or less in greatest dimension a Tumour 0.5 cm or less in greatest dimension b Tumour greater than 0.5 cm and no more than 1 cm in greatest dimension c Tumor greater than 1 cm but no more than 2 cm in greatest dimension\ Page 113 Pleural Mesothelioma Tumour involves ipsilateral parietal or visceral pleura only, with or without involvement of visceral, mediastinal or diaphragmatic pleura. Tumour involves ipsilateral parietal or visceral pleura only, with or without involvement of visceral, mediastinal or diaphragmatic pleura. 2

Page 143 p Melanoma Tumour 1 mm or less in thickness pa 0.8mm or less in thickness without ulceration pb 0.8mm or less in thickness with ulceration or more than 0.8mm but no more than 1mm in thickness, with or without ulceration p Tumour 1 mm or less in thickness pa less than 0.8mm in thickness without ulceration pb less than 0.8mm in thickness with ulceration or 0.8mm or more but no more than 1mm in thickness, with or without ulceration Page 179 Ovary Regional Lymph Nodes The regional lymph nodes are the hypogastric (obturator), common iliac, external iliac, lateral sacral, paraaortic, retroperitoneal, and inguinal nodes. Regional Lymph Nodes The regional lymph nodes are the hypogastric (obturator), common iliac, external iliac, lateral sacral, paraaortic, and retroperitoneal nodes* * Note *including intra-abdominal node such as greater omental nodes. Page 182 Ovary M Distant Metastasis M0 M1 No distant metastasis Distant metastasis M Distant Metastasis M0 No distant metastasis M1 Distant metastasis M1a Pleural effusion with positive cytology M1b Parenchymal metastasis and metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity) Stage Stage I N0 M0 Stage IA a N0 M0 Stage IB b N0 M0 Stage IC c N0 M0 Stage II T2 N0 M0 Stage IIA T2a N0 M0 3

Stage IIB T2b N0 M0 Stage IIC T2c N0 M0 Stage Stage I N0 M0 Stage IA a N0 M0 Stage IB b N0 M0 Stage IC c N0 M0 Stage II T2 N0 M0 Stage IIA T2a N0 M0 Stage IIB T2b N0 M0 Stage IIC T2c N0 M0 Page 188 Penis T Primary Tumour Tis Carcinoma in situ Ta Noninvasive verrucous carcinoma 1 Tumour invades subepithelial connective tissue a Tumour invades subepithelial connective tissue without lymphovascular invasion and is not poorly differentiated b Tumour invades subepithelial connective tissue with lymphovascular invasion or is poorly differentiated Note: 1 Verrucous carcinoma not associated with destructive invasion. Tis Carcinoma in situ (Penile intraepithelial neoplasia PeIN) Ta Noninvasive localized squamous cell carcinoma 1 Tumour invades subepithelial connective tissue 2 a Tumour invades subepithelial connective tissue without lymphovascular invasion or perineural invasion and is not poorly differentiated b Tumour invades subepithelial connective tissue with lymphovascular invasion or perineural invasion or is poorly differentiated Note: 1 Including verrucous carcinoma. 2 Glans: Tumor invades lamina propria Foreskin: Tumor invades dermis, lamina propria or dartos fascia Shaft: Tumor invades connective tissue between epidermis and corpora and regardless of location 4

Page 191, 193 Prostate T3 Tumour extends through the prostatic capsule 2 T3a Extracapsular extension (unilateral or bilateral) including microscopic bladder neck involvement T3 Tumour extends through the prostatic capsule 2 T3a Extraprostatic extension (unilateral or bilateral) including microscopic bladder neck involvement Prognostic Factor Grid Gleason Sum Score Page 196 199 T Primary Tumour Kidney T3 Tumour grossly extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota fascia T3a Tumour extends into the renal vein or its segmental (muscle containing) branches, or tumour invades perirenal and/or renal sinus fat (peripelvic) fat but not beyond Gerota fascia T3b Tumour grossly extends into vena cava below diaphragm T3c Tumour grossly extends into vena cava above the diaphragm or invades the wall of the vena cava T3 Tumour grossly extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota fascia T3a Tumour extends into the renal vein or its segmental (muscle containing) branches, or tumour invades the pelvicalyceal system or tumour invades perirenal and/or renal sinus fat (peripelvic) fat but not beyond Gerota fascia T3b Tumour grossly extends into vena cava below diaphragm T3c Tumour grossly extends into vena cava above the diaphragm or invades the wall of the vena cava 5

Page 204, 205 Urinary Bladder T2 Tumour invades muscle T2a Tumour invades superficial muscle (inner half) T2b Tumour invades deep muscle (outer half) Stage IVA T4b N0 M0 T2 Tumour invades muscularis propria T2a Tumour invades superficial muscularis propria (inner half) T2b Tumour invades deep muscularis propria (outer half) Stage IVA Any T Any N M1a Page 208 Urethra Urothelial (Transitional cell) carcinoma of the prostate Tis pu Tis pd Carcinoma in situ, involvement of prostatic urethra Carcinoma in situ, involvement of prostatic ducts Urothelial (Transitional cell) carcinoma of the prostate Tis pu Carcinoma in situ, involving the prostatic urethra, periurethral or prostatic ducts without stromal invasion Page 224 Malignant Melanoma of the Uvea Stage* Note *The stage groups are for malignant melanoma of the choroid and ciliary body but not the of the Iris 6